Meeting highlights. 65th annual scientific sessions of the American Diabetes Association, San Diego. Dual PPAR agonist improves glycemic control, lipids in type 2 diabetes.
D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D005998:Glycine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D024821:Metabolic Syndrome / Q000150:complications / Q000191:economics / Q000503:physiopathology; D010080:Oxazoles / Q000627:therapeutic use*; D000077205:Pioglitazone; D045162:Thiazolidinediones / Q000627:therapeutic use; D014481:United States
D007004:Hypoglycemic Agents; D010080:Oxazoles; D045162:Thiazolidinediones; D005998:Glycine; C500085:muraglitazar; D000077205:Pioglitazone